// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Serial FEV1 measurements: an improved diagnostic tool for occupational asthma?

Edward Parkes - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Occupational asthma: are we recognising at risk patients?

Paul Ellis - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Methadone hydrochloride

Sensitisation to mouse allergens in contemporary laboratory animal practice

Johanna Feary - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Specific inhalation challenge testing in consecutive patients with a wide range of occupational agents

Vicky Moore - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Redox-active metals impact the highest oxidative potential values in the urban and roadside locations in London

Nuria Camina - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

glutathione

Is the future of air pollution monitoring hiding in our pockets?

Michele Padovan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Oxidative stress, short-term exposure to air pollution, and lung function in children

Abigail Whitehouse - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Farmer's Lung Disease in a cohort of British agricultural workers

Christopher Barber - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Occupational exposures associated with pulmonary alveolar proteinosis

Kristin Cummings - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary alveolar proteinosis

N/A

Pubmed mining for occupational idiopathic pulmonary fibrosis papers

Carl Reynolds - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Characterisation of COPD exacerbations using personal environmental exposure monitoring

Benjamin Barratt - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Ventilation heterogeneity in children with severe asthma

Amy Nuttall - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Individualised field testing is a useful tool to evaluate difficult asthma

Gary Connett - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

High prevalence of abnormal lung function is seen in children managed for asthma in primary care

David Lo - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Airway inflammation in severe asthmatics with gastro-oesophageal reflux

Nicole Tanner - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

By how much can exhaled nitric oxide vary without a change in clinical status?

Shona Fielding - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Are there sub groups of children with asthma where FeNO guided treatment is associated with reduced risk for asthma attacks?

Stephen Turner - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors

Doxa Kotzia - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Phenotypes of young adults transitioning from paediatric to adult asthma services

Paul Griffiths - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care

Lesley Danvers - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved